| 763988 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
140 Allogeneic CAR T cells with deoxycytidine kinase knockdown demonstrate resistance to fludarabine |
2021-11-01 |
10.1136/jitc-2021-sitc2021.140 |
Pires Michelle, Martin Aaron |
| 763987 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
139 Chimeric antigen receptor macrophages (CAR-M) elicit a systemic anti-tumor immune response and synergize with PD1 blockade in immunocompetent mouse models of HER2+ solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.139 |
Pierini Stefano, Klichinsky Michael, Gabbasov Rashid, Worth Alison, Ramos Ilyssa, Blumenthal Daniel, Gabitova Linara, Abramson Sascha, Condamine Thomas, Ball Michael, Ohtani Yumi |
| 763986 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
137 Development of anti-Mucin1 CAR-T against solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.137 |
Lee Jihyun, Park Areum, Choi Jungwon, Yi Dae Gwan, Yang Hee Jung, Lee Hae-youn, Song Eurim, Jang Sung Woong, Yi Hyoju, Park Heedong, Jeun Eun-ji, Park Minjeong, Hong Peter |
| 763985 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
136 ATA3271: An armored, next-generation off-the-shelf, allogeneic, mesothelin-CAR T cell therapy for solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.136 |
Chen Xianhui, Liu Jiangyue, Yang Shuai, Oke Amogh, Davies Sarah, Ruiz-Juarez Bryan, Bulliard Yannick, Nguyen Cokey |
| 763984 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
133 CRISPR/Cas9 gene-edited allogeneic CAR-T cells targeting CD33 show high preclinical efficacy against AML without long-term hematopoietic toxicity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.133 |
Terrett Jonathan, Mcewan Brigid, Hostetter Daniel, Gamboa Luis, Kuppuraju Meghna, Ghonime Mohammed, Chain Robert, Padalia Zinkal, Kalaitzidis Demetrios |
| 763983 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
132 HLA-independent T cell receptors effectively target low abundance antigens |
2021-11-01 |
10.1136/jitc-2021-sitc2021.132 |
Mansilla-Soto Jorge, Eyquem Justin, Haubner Sascha, Hamieh Mohamad, Feucht Judith, Paillon Noémie, Zucchetti Andres, Li Zhuoning, Sjöstrand Maria, Lindenbergh Pieter, Saetersmoen Michelle, Maurin Mathieu, Iyer Archana, Dobrin Anton, Angus Andreina Garcia, Miele Matthew, Zhao Zeguo, Giavridis Theodoros, Stegen Sjoukje van der, Tamzalit Fella, Huse Morgan, Hendrickson Ronald, Hivroz Claire, Sadelain Michel |
| 763982 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
131 Genetic disruption of negative immune regulators to enhance CAR-T efficacy against solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.131 |
Mai David, Johnson Omar, June Carl |
| 763981 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
130 Engineered natural killer cells reactively block TIGIT and CD73 in the GBM microenvironment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.130 |
Lupo Kyle, Matosevic Sandro |
| 763980 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
128 KIR haplotype can inform donor selection production of allogeneic memory-like CAR NK cells for clinical application |
2021-11-01 |
10.1136/jitc-2021-sitc2021.128 |
Lemar Hadia, Vohra Anmol, Xie Ming-Hong, Chan Ivan, Lazetic Sasha, Trager James |
| 763979 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
126 Regional administration of IL-12 endowed CAR T cells effectively targets systemic disease |
2021-11-01 |
10.1136/jitc-2021-sitc2021.126 |
Lee Hee Jun, Cullen Cody, Murad John, Yang Jason, Chang Wen-Chung, Forman Stephen, Priceman Saul |
